Your browser doesn't support javascript.
loading
Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities
Maluf, Fernando; Soares, Andrey; Avanço, Guilherme; Hada, Aline Lury; Cardoso, Ana Paula Garcia; Carneiro, Arie; Herchenhorn, Daniel; Jardim, Denis Leonardo Fontes; Schutz, Fabio Augusto; Kater, Fabio Roberto; Pereira, Felipe Moraes Toledo; Monteiro, Fernando Sabino Marques; Morbeck, Igor Alexandre Protzner; Reolon, João Francisco Navarro; Trindade, Karine Martins da; Andrade, Livia Maria Querino da Silvo; Nogueira, Lucas Mendes; Furoni, Renato; Natel, Ricardo Azze; Reis, Rodolfo Borges dos; Fogace, Rodrigo Nogueira; Souza, Vinicius Carrera.
Affiliation
  • Maluf, Fernando; Hospital Beneficência Portuguesa. Departamento de Oncologia. São Paulo. BR
  • Soares, Andrey; Centro Paulista de Oncologia. São Paulo. BR
  • Avanço, Guilherme; Hospital Beneficência Portuguesa. Departamento de Oncologia. São Paulo. BR
  • Hada, Aline Lury; Hospital Israelita Albert Einstein. Departamento de Urologia. São Paulo. BR
  • Cardoso, Ana Paula Garcia; Hospital Israelita Albert Einstein. Departamento de Urologia. São Paulo. BR
  • Carneiro, Arie; Hospital Israelita Albert Einstein. Departamento de Urologia. São Paulo. BR
  • Herchenhorn, Daniel; Americano de Oncologia Cooperativa. Grupo Latino. Porto Alegre. BR
  • Jardim, Denis Leonardo Fontes; Hospital Sírio Libanês. Sociedade Beneficente de Senhoras. São Paulo. BR
  • Schutz, Fabio Augusto; Hospital Beneficência Portuguesa. Departamento de Oncologia. São Paulo. BR
  • Kater, Fabio Roberto; Hospital Beneficência Portuguesa. Departamento de Oncologia. São Paulo. BR
  • Pereira, Felipe Moraes Toledo; Hospital Beneficência Portuguesa. Departamento de Oncologia. São Paulo. BR
  • Monteiro, Fernando Sabino Marques; Hospital Universitário de Brasília. Unidade de Oncologia. Brasília. BR
  • Morbeck, Igor Alexandre Protzner; Universidade Catolica de Brasilia. Disciplina de Urologia. Taguatinga. BR
  • Reolon, João Francisco Navarro; Hospital Beneficência Portuguesa. Departamento de Oncologia. São Paulo. BR
  • Trindade, Karine Martins da; Hospital Haroldo Juacaba. Serviço de Urologia. Fortaleza. BR
  • Andrade, Livia Maria Querino da Silvo; Hospital São Rafael. Serviço de Urologia. Salvador. BR
  • Nogueira, Lucas Mendes; Universidade Federal de Minas Gerais. Hospital das Clínicas. Departamento de Cirurgia. Belo Horizonte. BR
  • Furoni, Renato; Hospital Beneficência Portuguesa. Departamento de Oncologia. São Paulo. BR
  • Natel, Ricardo Azze; Universidade Cidade de São Paulo. São Paulo. BR
  • Reis, Rodolfo Borges dos; Universidade de São Paulo. Faculdade de Medicina da Universidade. Ribeirão Preto. BR
  • Fogace, Rodrigo Nogueira; Hospital Israelita Albert Einstein. Departamento de Urologia. São Paulo. BR
  • Souza, Vinicius Carrera; Clínica AMO. Salvador. BR
Int. braz. j. urol ; 47(2): 359-373, Mar.-Apr. 2021. tab
Article in English | LILACS | ID: biblio-1154467
Responsible library: BR1.1
ABSTRACT
ABSTRACT

Background:

Non-metastatic castration resistant prostate cancer (M0 CRPC) has seen important developments in drugs and diagnostic tools in the last two years. New hormonal agents have demonstrated improvement in metastasis free survival in M0 CRPC patients and have been approved by regulatory agencies in Brazil. Additionally, newer and more sensitive imaging tools are able to detect metastasis earlier than before, which will impact the percentage of patients staged as M0 CRPC. Based on the available international guidelines, a group of Brazilian urology and medical oncology experts developed and completed a survey on the diagnosis and treatment of M0 CRPC in Brazil. These results are reviewed and summarized and associated recommendations are provided.

Objective:

To present survey results on management of M0 CRPC in Brazil. Design, setting, and

participants:

A panel of six Brazilian prostate cancer experts determined 64 questions concerning the main areas of interest 1) staging tools, 2) treatments, 3) side effects of systemic treatment/s, and 4) osteoclast-targeted therapy. A larger panel of 28 Brazilian prostate cancer experts answered these questions in order to create country-specific recommendations discussed in this manuscript. Outcome measurements and statistical

analysis:

The panel voted publicly but anonymously on the predefined questions. These answers are the panelists' opinions, not a literature review or meta-analysis. Therapies not yet approved in Brazil were excluded from answer options. Each question had five to seven relevant answers including two non-answers. Results were tabulated in real time.

Conclusions:

The results and recommendations presented can be used by Brazilian physicians to support the management of M0 CRPC patients. Individual clinical decision making should be supported by available data, however, for Brazil, guidelines for diagnosis and management of M0 CRPC patients have not been developed. This document will serve as a point of reference when confronting this disease stage.
Subject(s)


Full text: Available Collection: International databases Database: LILACS Main subject: Physicians / Prostatic Neoplasms, Castration-Resistant Type of study: Diagnostic study / Practice guideline / Prognostic study / Qualitative research Limits: Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Int. braz. j. urol Journal subject: Urology Year: 2021 Document type: Article Affiliation country: Brazil Institution/Affiliation country: Americano de Oncologia Cooperativa/BR / Centro Paulista de Oncologia/BR / Clínica AMO/BR / Hospital Beneficência Portuguesa/BR / Hospital Haroldo Juacaba/BR / Hospital Israelita Albert Einstein/BR / Hospital São Rafael/BR / Hospital Sírio Libanês/BR / Hospital Universitário de Brasília/BR / Universidade Catolica de Brasilia/BR

Full text: Available Collection: International databases Database: LILACS Main subject: Physicians / Prostatic Neoplasms, Castration-Resistant Type of study: Diagnostic study / Practice guideline / Prognostic study / Qualitative research Limits: Humans / Male Country/Region as subject: South America / Brazil Language: English Journal: Int. braz. j. urol Journal subject: Urology Year: 2021 Document type: Article Affiliation country: Brazil Institution/Affiliation country: Americano de Oncologia Cooperativa/BR / Centro Paulista de Oncologia/BR / Clínica AMO/BR / Hospital Beneficência Portuguesa/BR / Hospital Haroldo Juacaba/BR / Hospital Israelita Albert Einstein/BR / Hospital São Rafael/BR / Hospital Sírio Libanês/BR / Hospital Universitário de Brasília/BR / Universidade Catolica de Brasilia/BR
...